27578-Taza, Fadi
Fellow

Fadi Taza, MD

PGY 6
Damascus University

Bio

After graduating from Damascus University in Syria, I moved to Indy to work as a GU oncology research fellow, and then I spent 3 years in Baltimore to complete my Internal Medicine Residency training.

My current interest is real-world evidence that can help answer clinical and policy-relevant questions that cannot be directly answered using data from RCTs and provide unique insights into patients, treatments, and outcomes in routine oncology practice. Outside of medicine, I enjoy exploring new restaurants in Indy with my fiancé, cycling, hiking, and watching sports as much as I can! 

Key Publications

  1. Peer-Reviewed Journal Articles/Abstracts: 

    • Taza F, Chovanec M, Snavely A, Hanna NH, Cary C, Masterson TA, Foster RS, Einhorn LH, Albany C, Adra N. Prognostic Value of Teratoma in Primary Tumor and Postchemotherapy Retroperitoneal Lymph Node Dissection Specimens in Patients With Metastatic Germ Cell Tumor. Journal of Clinical Oncology. 2020, Mar; 38(12): 1338-1345. 

    • Taza F, Abonour R, Abu Zaid M, Althouse S, Anouti B, Akel R, Hanna N, Adra N, Einhorn L. Maintenance oral etoposide after high-dose chemotherapy (HDCT) for patients with relapsed metastatic germ-cell tumors (mGCT). Clin Genitourin Cancer. 2023 Jan 18.
    •  
    • Taza F, Holler AE, Fu W, Wang H, Adra N, Albany C, Ashkar R, Cheng HH, Sokolova AO, Agarwal N, Kessel A, Bryce A, Nafissi N, Barata P, Sartor AO, Bastos D, Smaletz O, Berchuck JE, Taplin ME, Aggarwal R, Sternberg CN, Vlachostergios PJ, Alva AS, Su C, Marshall CH, Antonarakis ES.
      Differential Activity of PARP Inhibitors in BRCA1- Versus BRCA2-Altered Metastatic Castration-Resistant Prostate Cancer. JCO Precis Oncol. 2021 Jul 22;5:PO.21.00070. doi: 10.1200/PO.21.00070. 

    • Albany C, Adra N, Snavely AC, Cary C, Masterson TA, Foster RS, Kesler K, Ulbright TM, Cheng L, Chovanec M, Taza F, Ku K, Brames MJ, Hanna NH, Einhorn LH. Multidisciplinary clinic approach improves overall survival outcomes of patients with metastatic germ-cell tumors. Annals of Oncology. 2018, Feb; 29(2): 341-346. 

    • Taza F, Chovanec M, Hahn N, Albany C. Long-Term Survival in a Patient With Metastatic DDR2-Positive Adrenal Cortical Carcinoma. Clinical Genitourinary Cancer. 2017, Oct; 15(5): e893-e895. 

    • Seidel C, Daugaard G, Tryakin A, Necchi A, Cedermark G, Sta°hl O, Hentrich M, Brito M, Albany C,Taza F, Gerl A, Oechsle K, Bokemeyer C. Intermediate prognosis in metastatic germ cell tumours-outcome and prognostic factors. European Journal of Cancer. 2018, May; 94(1): 16-25. 

    • Hamid A, Funt S.A, Markt S.C, Bromberg M, O'Donnell D, Adra N, Taza F, Albany C, Krailo M.D, Frazier L, Einhorn L, Feldman D.R, Sweeney C. Causes and patterns of mortality in patients with lethal germ cell tumor (GCT). Journal of Clinical Oncology. 2020, Feb; 38(6_suppl): 421-421. 

    • Chovanec M, Taza F, Kalra M, Hahn N, Nephew K, Spinella M, Albany C. Incorporating DNA Methyltransferase Inhibitors (DNMTis) in the Treatment of Genitourinary Malignancies: A Systematic Review. Targeted Oncology. 2017, Dec; 13(1): 49-60. 

    • Taza, F, Zulty M, Kanwal A, Grove D. Takotsubo Cardiomyopathy Triggered by SARS-CoV-2 Infection in a Critically ill Patient. BMJ journal. 2020, Jun; 13(6): e236561. 

    • Albany C, Adra N, Snavely A, Cary C, Masterson T, Foster R, Kesler K, Ulbright T, Cheng L, Chovanec M, Taza F, Hanna N, Einhorn L. Reply to the letter to the editor 'A centralised multidisciplinary clinic approach for germ cell tumours' by Crawford. Annals of Oncology. 2018, Nov; 29(11): 2264-2265. 

    • Taza, F, Kanwal, A, Zuly, M, Mustafa, S. High-grade pleomorphic rhabdomyosarcoma in a 60-year-old male: a case report and review of the literature. Journal of Community Hospital Internal Medicine Perspectives. 2020, Jun; 10(3): 287-289. 

    • Seidel C, Daugaard G, Tryakin A, Necchi A, Cedermark G, Sta°hl O, Hentrich M, Brito M, Albany C, Taza F, Gerl A, Oechsle K, Oing C, Bokemeyer C. The prognostic impact of different tumor marker levels in nonseminomatous germ cell tumor patients with intermediate prognosis: A registry of the International Global Germ Cell Tumor Collaborative Group (G3). Urologic Oncology: Seminars and Original Investigations. 2019, Nov; 37(11): 809.e19-809.e25. 

    • Taza F, Suleman N, Paz R, Haas C. Acquired Hemophilia A and Urothelial Carcinoma. Journal of Community Hospital Internal Medicine Perspectives. 2020, Jun. 

    • Taza F, Shahda S. Everolimus and Octreotide in a Patient with High-Grade Pancreatic Neuroendocrine Carcinoma. Journal of the Pancreas. 2017, Sep; 18(5): 436-439. 

    • Kanwal A, Zulty M, Taza F, Patel, B.M. Pericardial Angiosarcoma Presenting as Cardiac Tamponade. The Journal of American College of Cardiology. 2020, Mar; 75(11): 2658.

     

Poster Presentations: 

American Society of Clinical Oncology (ASCO) 2022 Annual Meeting:
Taza F, Abonour R, Althouse S, Ashkar R, Abu Zaid M, Hanna N, Kessler K, Adra N, Einhorn L. Salvage high-dose chemotherapy (HDCT) for relapsed primary mediastinal nonseminomatous germ-cell tumors (PMNSGCT). Poster presented at ASCO 2022 meeting; Chicago, IL, USA

Genitourinary Cancers Symposium (GU ASCO) 2021 Annual Meeting:
Taza F, Holler AE, Adra N, Ashkar R, Sokolova AO, Kessel A, Nafissi N, Barata P, Bastos D, Smaletz O, Berchuck JE, Aggarwal R, Vlachostergios PJ, Su C, Marshall CH, Antonarakis ES.

Differential activity of PARP inhibitors in BRCA1- versus BRCA2-altered metastatic castration-resistant prostate cancer presented at ASCO GU 2021 meeting.

American Society of Clinical Oncology (ASCO) 2018 Annual Meeting:
Taza F, Chovanec M, Snavely A, Adra N, Hanna N, Cary C, Masterson T, Einhorn L, Albany C. (June 2018). The prognostic value of teratoma in the primary tumor and postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) specimens in patients with germ cell tumors (GCTs) Poster presented at ASCO 2018 meeting; Chicago, IL, USA

American Society of Clinical Oncology (ASCO) 2018 Annual Meeting:
Taza F, Chovanec M, Snavely A, Adra N, Hanna N, Cary C, Masterson T, Einhorn L, Albany C. (June 2018). Retroperitoneal cancer viability after postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) in good risk germ cell tumors (GCTs) Poster presented at ASCO 2018 meeting; Chicago, IL, USA.

Genitourinary Cancers Symposium (GU ASCO) 2020 Annual Meeting:
Hamid A, Funt S.A, Markt S.C, Bromberg M, O'Donnell D, Adra N, Taza F, Albany C, Krailo M.D, Frazier L, Einhorn L, Feldman D.R, Sweeney C. Causes and patterns of mortality in patients with lethal germ cell tumor (GCT). Poster presented at ASCO GU 2020 meeting; San Francisco, California, USA.

European Society for Medical Oncology 2018 Annual Meeting:
Seidel C, Daugaard G, Tryakin A, Necchi A, Cedermark G, Sta°hl O, Hentrich M, Brito M, Albany C, Taza F, Gerl A, Oechsle K, Bokemeyer C. Intermediate prognosis in metastatic germ cell tumours-outcome and prognostic factors. Poster presented at ESMO 2018 Congress, Munich, Germany.

  • Education
    2015 MD Damascus University
  • Professional Organizations
    American Society of Clinical Oncology (ASCO)
    American Society of Hematology
  • Board Certifications
    American Board of Internal Medicine - Adolescent Medicine
  • Awards
    Org: Indiana University Hematology and Oncology Department
    Desc: Arthur Griffith Fellow
    Scope: University
    Date: 2022-04-22

Looking for patient care?

To schedule an appointment with a faculty member physician of IU School of Medicine, contact Indiana University Health at 888-484-3258 or use the physician finder by clicking the button below.

Find a doctor